Milk-induced Gastrointestinal Symptoms in Infants
Primary Purpose
Gastrointestinal Symptoms in Young Infants
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Formula milk free of cow's milk protein
Placebo
Sponsored by
About this trial
This is an interventional diagnostic trial for Gastrointestinal Symptoms in Young Infants focused on measuring Constipation, Gastroeosphageal reflux, Colics
Eligibility Criteria
Inclusion Criteria:
- Infants 0-6 month old with at least one of the following symptoms : constipation, gastroesophageal reflux, colics
Exclusion Criteria:
- Prematurity
- exclusive breastfeeding
- Other cause for symptoms
Sites / Locations
- Département de l'enfant et de l'adolesent - Hôpitaux Universitaires de Genève
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
Infant formula milk
Formula milk free of milk proteins
Arm Description
Infant formula milk adapted to age of infant
Milk-free formula milk adapted to age of infant
Outcomes
Primary Outcome Measures
Milk allergy in gastrointestinal diseases in young infants
Establish the role of milk proteins in gastrointestinal diseases in young infants
Secondary Outcome Measures
Diagnostic tests
Determine the diagnostic value of immunological tests in these pathologies
Full Information
NCT ID
NCT01684319
First Posted
September 10, 2012
Last Updated
January 3, 2014
Sponsor
University Hospital, Geneva
1. Study Identification
Unique Protocol Identification Number
NCT01684319
Brief Title
Milk-induced Gastrointestinal Symptoms in Infants
Official Title
Prospective, Randomized, Double Blind and Placebo Controlled Study With the Aim to Establish the Role of Milk Proteins in Gastrointestinal Diseases (GERD, Constipation and Colics) of Young Infants and to Determine the Diagnostic Value of Immunological Tests in These Pathologies.
Study Type
Interventional
2. Study Status
Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
August 2013 (Actual)
Study Completion Date
November 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Geneva
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Various digestive manifestations are common in infants less than 6 months and have a significant impact on morbidity and quality of life of the family. In a prospective study on more than 2800 Italian infants followed by 0-6 months of life, it was determined that 55% of these children had gastrointestinal symptoms such as regurgitation (23%), colics (20%), constipation (17%) or poor weight gain (15%). However, these symptoms are not very accurate, and their cause is often difficult to determine. Frequently, the pediatrician will exclude cow's milk protein in infant feeding, but without a clear etiological diagnosis was asked. This measure causes significant additional costs through the use of extensively hydrolyzed milk specifically for children and involves an elimination diet of all foods containing cow's milk sometimes for several years. This can negatively influence the growth of the child.
If the involvement of milk in these pathologies is suggested by some early studies (35% for colics, 68% in constipation, 42% in gastroesophageal reflux), it is unclear in the current state of knowledge if these gastrointestinal symptoms are actually due to an "allergy" to milk. Moreover, there is no validated diagnostic test for non-IgE-mediated gut allergy. However, various tests have proven their effectiveness in the investigation of non IgE-mediated allergy (eg. LAT, patch tests) and will be used in this study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastrointestinal Symptoms in Young Infants
Keywords
Constipation, Gastroeosphageal reflux, Colics
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Infant formula milk
Arm Type
Placebo Comparator
Arm Description
Infant formula milk adapted to age of infant
Arm Title
Formula milk free of milk proteins
Arm Type
Active Comparator
Arm Description
Milk-free formula milk adapted to age of infant
Intervention Type
Dietary Supplement
Intervention Name(s)
Formula milk free of cow's milk protein
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Infant formula milk
Primary Outcome Measure Information:
Title
Milk allergy in gastrointestinal diseases in young infants
Description
Establish the role of milk proteins in gastrointestinal diseases in young infants
Time Frame
10 weeks
Secondary Outcome Measure Information:
Title
Diagnostic tests
Description
Determine the diagnostic value of immunological tests in these pathologies
Time Frame
10 weeks
10. Eligibility
Sex
All
Maximum Age & Unit of Time
6 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Infants 0-6 month old with at least one of the following symptoms : constipation, gastroesophageal reflux, colics
Exclusion Criteria:
Prematurity
exclusive breastfeeding
Other cause for symptoms
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Philippe A Eigenmann, MD
Organizational Affiliation
Hôpitaux Unversitaire de Genève
Official's Role
Study Director
Facility Information:
Facility Name
Département de l'enfant et de l'adolesent - Hôpitaux Universitaires de Genève
City
Genève
State/Province
GE
ZIP/Postal Code
1211
Country
Switzerland
12. IPD Sharing Statement
Learn more about this trial
Milk-induced Gastrointestinal Symptoms in Infants
We'll reach out to this number within 24 hrs